TAF1 and cancer: In this study, TAF1 was proposed as a promising target for SNSCC therapy due to its (i) central role as an upregulated hub protein in SNSCC, (ii) involvement in transcriptional and histone modification, and (iii) overexpression in several cancer types, as revealed by a literature review.